The open index of psychedelic research

Open datasets, papers, preregistrations, and trials from across psychedelic science.

11,281 records6 sources
Showing 769–792 of 11,281
ArticleMDMA

Prevalence of Potential Contraindications and Risk Factors Relevant to MDMA-Assisted Therapy Among U.S. Veterans with Posttraumatic Stress Disorder.

Hwang CS, Cameron DC, O'Neill AC +4

Europe PMC2026
ArticleKetamine

Last resort: the ethical obligation to offer ketamine in psychiatric euthanasia and assisted suicide.

Zhang J, Sisti D

Europe PMC2026
ProjectKetamine

Prehospital Use of Fentanyl and Ketamine for Burn Pain: A Scoping Review

OSF2026
PreprintPsilocybin

Mapping excitatory synaptic plasticity evoked by single-dose psilocybin in mice

Li Z, Weber C, Sellitti F +1

Europe PMC2026
ArticlePsychedelics

Blinding Integrity and Psychedelic Drug Trials-Reply.

Cubala WJ, Valcheva V, Thase ME

Europe PMC2026
ArticlePsychedelics

Blinding Integrity and Psychedelic Drug Trials.

Hsu TW, Liang CS, Tu YK

Europe PMC2026
ArticlePsychedelics

Blinding Integrity and Psychedelic Drug Trials.

Elliott M, Chernoloz O

Europe PMC2026
DatasetPsychedelics

Environmental and Endogenous Psychedelics as Adaptive Plasticity Modulators: An Integrative Systems Biology Framework

Genc, Kaya, John, Silas Njiru, Barkell, James

Zenodo2026
ArticlePsilocybin

Psychedelics and women's mental health: the effects of female sex hormones on psychedelics' efficacy and tolerability.

Kuypers KPC, Mason NL, Carlier A +2

Europe PMC2026
ArticleKetamine

New treatments for treatment-resistant depression: esketamine controversies - a narrative review.

Vinberg M

Europe PMC2026
ArticleKetamine

Intravenous ketamine for complex regional pain syndrome: Pain outcomes and predictors of response. A systematic review and meta‑analysis.

van den Brink J, van der Spek DPC, Baart SJ +2

Europe PMC2026
PreprintKetamine

Ultrasonic potentiation of ketamine neuromodulation

Roy KS, Martinez P, Ewbank SN +4

Europe PMC2026
ArticleKetamine

Recreational ketamine exposure disrupts redox and inflammatory homeostasis in salivary glands and plasma leading to salivary dysfunction.

Lima-da-Silva ECS, Chagas CKS, Melo WWP +9

Europe PMC2026
ArticleMDMA

Integrated biomarker analysis of multi-organ effects following MDMA and alcohol co-consumption in Pakistan: A pilot study.

Jaleel A, Khan M, Namoos K +5

Europe PMC2026
ArticleLSD

Targeting peripheral 5-HT<sub>2A</sub>R enhances antitumor immunity in colorectal cancer.

Wen Y, Tang L, Duan W +22

Europe PMC2026
DatasetPsychedelics

Reconstructing Scientific Knowledge: A Multidimensional Framework for Understanding Evidence, Causality, and Observable Phenomena in Objective Reality

Genc, Kaya, John, Silas Njiru, Barkell, James

Zenodo2026
ProjectPsychedelics

Evidence Table: SDT Perspective on Psychedelic Integration (EHPC 2026 Poster Supplement)

OSF2026
PreprintPsychedelics

Mind-manifesting? Examining naturalistic reports from psychedelics, cannabis, meditation, and dreams from the ALTERD mobile application

Murray CH, Angyus M, Suchin S +2

Europe PMC2026
PreprintPsychedelics

Flattened brain hierarchy and increased EEG complexity during unusual bodily experiences and out-of-body experiences

Campillo-Ferrer T, Berjaga-Buisan T, Iadarola A +8

Europe PMC2026
ArticlePsilocybin

Where is the sweet spot for psychedelic-enhanced fear extinction? An integrative quantitative synthesis of dose-effect patterns in rodent models.

Werle I, Probst MEC, Bertoglio LJ

Europe PMC2026
ArticleDMT

Psychological change processes in alcohol use disorder: A qualitative study of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) with cognitive behavioural therapy.

Seynaeve M, Dunbar F, Ermakova AO +4

Europe PMC2026
ArticlePsilocybin

Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin Services.

Korthuis PT, Cook RR, Gregoire D +8

Europe PMC2026
ArticlePsilocybin

Safety and Efficacy of Psilocybin During Anticancer Treatment: A Phase II Trial Secondary Analysis.

Schaefer DA, Agrawal M, Mazzola E +4

Europe PMC2026
PreprintPsilocybin

Music for Psilocybin Therapy and the Temporal Arc of Psychedelic Experience

Gómez-Cañón JS, Leininger C, Mayall D +2

Europe PMC2026